Change over period
From:
To:
Zoom:
- 1Y
- 3Y
- 5Y
- 10Y
- 15Y
- 20Y
- Max
Beauty Health Co
NASDAQ SKIN
Data sourced from
and
and
Beauty Health Co Gross Profit Margin for the Trailing 12 Months (TTM) ending March 31, 2024: 37.87%
Beauty Health Co Gross Profit Margin is 37.87% for the Trailing 12 Months (TTM) ending March 31, 2024, a -43.41% change year over year. Gross Profit Margin represents the percentage of revenue that represents gross profit, indicating the efficiency of a company's production and pricing.
-
Beauty Health Co Gross Profit Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was 66.91%, a -3.06% change year over year.
-
Beauty Health Co Gross Profit Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was 69.03%, a 29.90% change year over year.
-
Beauty Health Co Gross Profit Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was 53.14%, a -8.66% change year over year.
-
Beauty Health Co Gross Profit Margin for the Trailing 12 Months (TTM) ending March 31, 2020 was 58.18%.
Don’t Miss A Beat
Looking to stay ahead of the competition and stay informed? Receive your daily dose of market news, trends, and analysis to kickstart your day and stay up-to-date.
NASDAQ: SKIN
| CEO | Mr. Brenton L. Saunders J.D. |
| IPO Date | Nov. 24, 2020 |
| Location | United States |
| Headquarters | 2165 Spring Street, Long Beach, CA, United States, 90806 |
| Employees | 881 |
| Sector | Consumer Defensive |
| Industry | Household & personal products |
Description
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.
Key trends
Similar companies
GXO Logistics Inc
NA
NA
StockViz Staff
September 20, 2024
Any question? Send us an email